This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
BC200-Driven Translational Regulation as a Therapeutic Target and Biomarker in Tubo-Ovarian High-Grade Serous Carcinoma
Electrochemical Quantification of Chemotherapy Resistance
Delving deeper into chaos of ovarian cancer genomes—from telomere-to-telomere
In vivo modelling of chromosome instability in tubo-ovarian high grade serous carcinoma
The Manitoba Ovarian Cancer Biobank Program (MOBP)
Testing the in vitro mechanism and in vivo efficacy of an experimental drug to kill epithelial ovarian cancer
Patient-centred Hereditary Ovarian Cancer Prevention and Survivorship Care in Canada
Precision medicine for patients with co-existent ovarian and endometrial cancer: the COMPARE trial
Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer
Prevalence and Experience of Traumatic Stress in Patients with Newly Diagnosed and Recurrent Advanced Ovarian Cancer
